A following more detailed study, including patients with active rheumatoid arthritis and high insulin resistance, confirmed these findings while it also proved restoration of mediators' phosphorylation in the insulin signaling cascade, after 12 weeks of treatment with anti-TNF agents [21]. The gene discussed is INS; the disease is Insulin resistance.